February 10, 2020 / 12:23 PM / 17 days ago

BRIEF-Allergan Reports Q4 Loss Per Share Of $0.97

Feb 10 (Reuters) - Allergan Plc:

* ALLERGAN REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

* Q4 GAAP LOSS PER SHARE $0.97

* Q4 EARNINGS PER SHARE ESTIMATE $4.57 — REFINITIV IBES DATA

* QTRLY NON-GAAP PERFORMANCE NET INCOME PER SHARE OF $5.22

* QTRLY TOTAL NET REVENUES $4,351.0 MILLION VERSUS $4,079.7 MILLION

* SEES EXPECTS CLOSE OF PENDING ABBVIE TRANSACTION AROUND END OF Q1 2020

* DUE TO PENDING ABBVIE TRANSACTION, CO NOT HOSTING CONFERENCE CALL TO DISCUSS Q4 AND FY 2019 RESULTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below